Relevant bibliographies by topics / Pharmaceutical care / Journal articles
To see the other types of publications on this topic, follow the link: Pharmaceutical care.

Journal articles on the topic 'Pharmaceutical care'

Author: Grafiati
Published: 4 June 2021
Last updated: 15 June 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pharmaceutical care.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Chrisp, Paul. "Pharmaceutical care." Inpharma Weekly &NA;, no. 894 (1993): 5–6. http://dx.doi.org/10.2165/00128413-199308940-00008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

KIELGAST, PETER J. "Pharmaceutical care." International Journal of Pharmacy Practice 2, no. 3 (1993): 125–26. http://dx.doi.org/10.1111/j.2042-7174.1993.tb00742.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hepler, Charles D. "Pharmaceutical care." Pharmacy World and Science 18, no. 6 (1996): 233–35. http://dx.doi.org/10.1007/bf00735965.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Allwood, M. C., C. L. Ronchera-Oms, T. Sizer, B. McElroy, and G. Hardy. "From pharmaceutics to pharmaceutical care in nutritional support." Clinical Nutrition 14, no. 1 (1995): 1–3. http://dx.doi.org/10.1016/s0261-5614(06)80002-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hopefl, Alan W. "Costs of Pharmaceutical Care: Can the Profession do Anything?" Annals of Pharmacotherapy 26, no. 12 (1992): 1585–88. http://dx.doi.org/10.1177/106002809202601219.

Full text
Abstract:
OBJECTIVE: To review some of the factors that influence the cost of pharmaceuticals and the delivery of pharmaceutical care as well as some possible measures for decreasing these costs. DATA SYNTHESIS: Clinical studies have been selected to illustrate factors that may add to the overall cost of pharmaceutical care. CONCLUSIONS: Because of the perceived problems resulting from the introduction of new, expensive pharmaceuticals, possible means of controlling the costs of individual products are discussed. In addition, recommendations for achieving cooperation between pharmaceutical manufacturers and pharmacy practitioners in demonstrating the cost-effectiveness of new products are provided.
APA, Harvard, Vancouver, ISO, and other styles
6

Laven, David L., and William B. Hladik. "Pharmaceutical Care and Diagnostic Pharmaceuticals: Patient Care Avenues Not to Be Overlooked." Journal of Pharmacy Practice 7, no. 3 (1994): 79–83. http://dx.doi.org/10.1177/089719009400700302.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bomfim, José Henrique Gialongo Gonçales. "Pharmaceutical Care in Sports." Pharmacy 8, no. 4 (2020): 218. http://dx.doi.org/10.3390/pharmacy8040218.

Full text
Abstract:
Pharmaceutical care in sports is a new field of work to clinical pharmacists, focused on promoting pharmacotherapeutic follow up and clinical services to athletes, physical activity practitioners and enthusiasts of any sports modality. A broad range of pharmaceuticals, dietary supplements and herbal drugs have been used historically as performance promoters, doping or ergogenic aids. In this context, the role of pharmacists in prevent adverse events, drug interactions or any drug related problems, as doping issues, was described. Its actions can be important to contribute with a multi professional clinical health team, leading athletes to use these resources in a rational way, promoting and optimizing the therapeutic when its necessary.
APA, Harvard, Vancouver, ISO, and other styles
8

Manasse, Henri R. "The Care in Pharmaceutical Care." Journal of Pharmacy Teaching 3, no. 3 (1992): 39–52. http://dx.doi.org/10.1300/j060v03n03_06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hill, Peter. "Pharmaceutical care R.I.P?" International Journal of Pharmacy Practice 20, no. 1 (2012): 2–3. http://dx.doi.org/10.1111/j.2042-7174.2011.00184.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Morley, P. C. "Pharmaceutical care: desiderata." Journal of Clinical Pharmacy and Therapeutics 18, no. 3 (1993): 143–46. http://dx.doi.org/10.1111/j.1365-2710.1993.tb00604.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Zellmer, William A. "Implementing Pharmaceutical Care." American Journal of Health-System Pharmacy 50, no. 2 (1993): 378. http://dx.doi.org/10.1093/ajhp/50.2.378.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Dole, Ernest J. "Beyond pharmaceutical care." American Journal of Health-System Pharmacy 51, no. 17 (1994): 2183–84. http://dx.doi.org/10.1093/ajhp/51.17.2183.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Low, John. "Whither Pharmaceutical Care?" Australian Journal of Hospital Pharmacy 28, no. 2 (1998): 79–80. http://dx.doi.org/10.1002/jppr199828279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Miller, Lucinda. "Pharmaceutical Care and Health Care Reform." Journal of Pharmacoepidemiology 4, no. 2 (1996): 3–6. http://dx.doi.org/10.1300/j055v04n02_02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Rodriguez, Louise R. "Health care reform and pharmaceutical care." American Journal of Health-System Pharmacy 51, no. 11 (1994): 1467–68. http://dx.doi.org/10.1093/ajhp/51.11.1467.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Dzionek, Jacqueline. "Pharmaceutical Care in Ontario." Journal of Medical Science 89, no. 4 (2020): e458. http://dx.doi.org/10.20883/medical.e458.

Full text
Abstract:
Pharmaceutical care is an integral part of global healthcare. Indeed, pharmacists are recognised as a primary point of care, providing many services to optimise the patient’s healthcare. The article provides insight on how expanding the scope of pharmacists’ practice can facilitate collaboration between healthcare providers, relieve the workload of the physicians, also providing patients with optimal healthcare service globally. This article focuses specifically on the expanded scope of pharmacists in Ontario, Canada and the services that pharmacists can provide in the pharmacy for all patients.
APA, Harvard, Vancouver, ISO, and other styles
17

Ito, Yuki. "Practice of Pharmaceutical Care." Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 32, no. 6 (2006): 473–81. http://dx.doi.org/10.5649/jjphcs.32.473.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Rysiak, Edyta, Ewelina Bogdańska, Milena Osińska, et al. "Pharmaceutical care for asthma." Farmacja Polska 74, no. 3 (2018): 184–88. http://dx.doi.org/10.32383/farmpol/119195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Elliott, Roger K., and Kenneth D. Crist. "Provision of pharmaceutical care." American Journal of Health-System Pharmacy 47, no. 7 (1990): 1530. http://dx.doi.org/10.1093/ajhp/47.7.1530a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Buerki, Robert A. "Ethics and Pharmaceutical Care." Journal of Pharmacy Teaching 5, no. 1-2 (1996): xi—xii. http://dx.doi.org/10.1300/j060v05n01_a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Ramaswamy-Krishnarajan, John, and David S. Hill. "Pharmaceutical Care in Canada." Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 138, no. 4 (2005): 46–50. http://dx.doi.org/10.1177/171516350513800409.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Shane, Rita R. "Prerequisites for pharmaceutical care." American Journal of Health-System Pharmacy 49, no. 11 (1992): 2790–91. http://dx.doi.org/10.1093/ajhp/49.11.2790.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Lee, M. Patricia, and Max D. Ray. "Planning for Pharmaceutical Care." American Journal of Health-System Pharmacy 50, no. 6 (1993): 1153–58. http://dx.doi.org/10.1093/ajhp/50.6.1153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Strand, Linda M., and Robert J. Cipolle. "Challenges for Pharmaceutical Care." American Journal of Health-System Pharmacy 50, no. 8 (1993): 1618–21. http://dx.doi.org/10.1093/ajhp/50.8.1618.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Zellmer, William A. "Reflections on Pharmaceutical Care." American Journal of Health-System Pharmacy 50, no. 8 (1993): 1778. http://dx.doi.org/10.1093/ajhp/50.8.1778.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Kimbel, KarlH. "Pharmaceutical care in Germany." Lancet 343, no. 8908 (1994): 1283. http://dx.doi.org/10.1016/s0140-6736(94)92170-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Cohen, Michael R. "Pharmaceutical (Who) Care(s)?" American Pharmacy 35, no. 11 (1995): 37–40. http://dx.doi.org/10.1016/s0160-3450(15)30026-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Winckler, Susan C. "Consensus About Pharmaceutical Care." American Pharmacy 35, no. 3 (1995): 4. http://dx.doi.org/10.1016/s0160-3450(15)30184-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Manolakis, Patti Gasdek. "Developing Pharmaceutical Care Protocols." American Pharmacy 35, no. 2 (1995): 67. http://dx.doi.org/10.1016/s0160-3450(15)30215-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Martin, Sara. "Pharmaceutical Care Made Easy." American Pharmacy 34, no. 3 (1994): 61–64. http://dx.doi.org/10.1016/s0160-3450(15)30484-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Cauffield, Jacintha S., and John G. Gums. "Book Review: Pharmaceutical Care." Annals of Pharmacotherapy 31, no. 2 (1997): 257. http://dx.doi.org/10.1177/106002809703100229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Hawkins, Patti R., Stacie L. McMillan, and Harold J. Kornfuhrer. "Moving toward pharmaceutical care." American Journal of Health-System Pharmacy 53, no. 22 (1996): 2747–50. http://dx.doi.org/10.1093/ajhp/53.22.2747.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Yoshiyama, Yuji. "Pharmacology for Pharmaceutical Care." Proceedings for Annual Meeting of The Japanese Pharmacological Society 96 (2022): 4—B—S36–1. http://dx.doi.org/10.1254/jpssuppl.96.0_4-b-s36-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Isetts, Brian J. "Dynamics of Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 36, no. 9 (1996): 551. http://dx.doi.org/10.1016/s1086-5802(16)30132-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Marcrom, Ray E., Robin M. Horton, and Marvin D. Shepherd. "Dynamics of Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 36, no. 10 (1996): 606. http://dx.doi.org/10.1016/s1086-5802(16)30146-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

de Bittner, Magaly Rodriguez, and Robert Michocki. "Dynamics of Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 37, no. 5 (1997): 595–96. http://dx.doi.org/10.1016/s1086-5802(16)30257-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Munroe, Wendy P., and Thomas Rosenthal. "Dynamics OF Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 37, no. 6 (1997): 705. http://dx.doi.org/10.1016/s1086-5802(16)30270-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Srnka, Quentin M. "Dynamics of Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 38, no. 2 (1998): 235. http://dx.doi.org/10.1016/s1086-5802(16)30321-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

McDonough, Randy P., Elizabeth S. Pithan, William R. Doucette, and Michael J. Brownlee. "Marketing Pharmaceutical Care Services." Journal of the American Pharmaceutical Association (1996) 38, no. 6 (1998): 667–95. http://dx.doi.org/10.1016/s1086-5802(16)30401-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Ferst, Kenneth. "Dynamics of Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 40, no. 5 (2000): 675–76. http://dx.doi.org/10.1016/s1086-5802(16)31116-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

McDonough, Randal P., and William R. Doucette. "Dynamics of Pharmaceutical Care." Journal of the American Pharmaceutical Association (1996) 41, no. 5 (2001): 682–92. http://dx.doi.org/10.1016/s1086-5802(16)31315-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Mil, J. W. F. "Pharmaceutical Care Made Easy." Pharmacy World & Science 29, no. 5 (2007): 516. http://dx.doi.org/10.1007/s11096-007-9088-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

MacAulay, Keith. "PSA and Pharmaceutical Care." Australian Journal of Hospital Pharmacy 27, no. 5 (1997): 412. http://dx.doi.org/10.1002/jppr1997275412a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Awiphan, Ratanaporn, та Unchalee Thadapark. "Pharmaceutical Care Scales and Thai Hospital Pharmacists’ Attitude toward Pharmaceutical Care(แบบวัดการบริบาลเภสัชกรรมและทัศนคติต่องานบริบาลเภสัชก..." Thai Journal of Pharmaceutical Sciences 27, № 1 (2003): 59–71. http://dx.doi.org/10.56808/3027-7922.2270.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Kushida, Kazuki, and Masayoshi Hirohara. "Advanced Pharmaceutical Management Functions in Home Pharmaceutical Care." YAKUGAKU ZASSHI 140, no. 7 (2020): 877–84. http://dx.doi.org/10.1248/yakushi.19-00237-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Pitterle, Michael E., C. A. Bond, and Cynthia L. Raehl. "Pharmaceutical-care index for measuring comprehensive pharmaceutical services." American Journal of Health-System Pharmacy 49, no. 9 (1992): 2226–29. http://dx.doi.org/10.1093/ajhp/49.9.2226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Smythe, Maureen A., Prakash P. Shah, Terry L. Spiteri, Richard L. Lucarotti, and Robert L. Begle. "Pharmaceutical Care in Medical Progressive Care Patients." Annals of Pharmacotherapy 32, no. 3 (1998): 294–99. http://dx.doi.org/10.1345/aph.17068.

Full text
Abstract:
OBJECTIVE: To develop, implement, and assess the outcomes of a system for providing pharmaceutical care to medical progressive care patients. METHODS: A system for providing pharmaceutical care was developed and implemented for an 8-week period beginning in June 1995. Both patient care outcomes and drug therapy cost change from the intervention period were compared with those of an 8-week baseline period. Variables compared included unit length of stay, hospital length of stay, transfers to the intensive care unit, readmissions, and adverse drug reactions requiring treatment. Differences between periods for these variables were assessed by using χ2 tests and t-tests with α set at p less than 0.05. The clinical significance of the interventions were assessed independently by four physicians: two intensivists and two internists. The total drug therapy cost change from the intervention period was calculated as follows: total cost avoidance from individual recommendations subtracted from the total cost incurred from individual recommendations. RESULTS: The pharmacist evaluated 152 patients during the intervention period. A total of 235 pharmacotherapy recommendations were made on 103 patients, of whom 86.4% were accepted. Significantly fewer adverse drug reactions (ADRs) received treatment during the intervention period (p = 0.027). The mean unit length of stay was lower during the intervention period (4.8 ± 3.7 d) than during the baseline period (6.0 ± 5.6 d); however, this difference was not significant (p = 0.053). Individual physician assessment of the pharmacists' recommendations revealed that 75.8% were considered somewhat significant, significant, or very significant. The total drug therapy cost change from the intervention period was –$6534.53. The projected annual drug therapy cost reduction from this study is $42 474.45. CONCLUSIONS: The provision of pharmaceutical care to medical progressive care patients was associated with a substantial decrease in drug therapy cost and a decrease in the number of ADRs that required treatment. OBJETIVO: Desarrollar, implementar, y evaluar los resultados de un sistema que provee atención farmacéutica a pacientes en una unidad de cuidado intensivo. MÉTODOS: Un sistema para la provisión de atención farmacéutica fue desarrollado e implementado por un período de 8 semanas comenzando en junio de 1995. Se compararón los resultados clínicos de los pacientes y el costo de los cambios en terapia antes de implementarse el sistema 8 semanas antes y luego de su implementación por un período de 8 semanas. Las variables que se compararón incluyen duración de estadía en el hospital y en la unidad de cuidado intensivo, traslados a la unidad de cuidado intensivo, re-admisiones, y reacciones adversas que requirieron tratamiento. La diferencia entre las variables se analizó usando la pruebas estadísticas de χ2 y de t-test con un alpha de p < 0.05. El significado clínico de las intervenciones hechas por el farmacéutico fue evaluado individualmente por cuatro de los médicos: dos internistas y dos especialistas en cuidado intensivo. El costo total de los cambios en la terapia durante el período de estudio se calculó de la siguiente manera: el costo total ahorrado como consequencia de las recomendaciones individuales del farmacéutico menos el costo total incurrido como consequencia de las recomendaciones individuales del farmacéutico. RESULTADOS: Un total de 152 pacientes fueron evaluados por el farmacéutico durante el período de estudio. Se hicierón 235 recomendaciones farmacoterapéuticas en 103 pacientes, de las cuales 86.4% fueron aceptadas por los médicos. Durante el período de estudio hubieron muchas menos reacciones adversas comparadas con las que ocurrierón antes del estudio (p = 0.027). La unidad promedio de estadía en el hospital fue menor durante el período de intervención (4.8 ± 3.7 d) que durante el período antes de la intervención (6.0 ± 5.6 d); sin embargo, esta diferencia no fue estadistícamente significativa (p = 0.053). Las evaluaciones individuales de las recomendaciones de los farmacéuticos por parte de los médicos, reveló que 75.8% de las recomendaciones fueron catalogadas como algo significativas, significativas, o muy significativas. El total del costo de la terapia fue de $6534.53 menos que antes de la intervención. El ahorro anual proyectado se estimó en $42 474.45. CONCLUSIONES: La provisión de atención farmacéutica en una unidad de cuidado intensivo fue asociada con una baja en el costo de la terapia con medicamentos y en el número de reacciones adversas que necesitarón tratamiento. INTRODUCTION: Développer un système de soins pharmaceutiques pour une unité de soins progressifs, de le mettre en application, et d'en évaluer l'efficacité. MÉTHODES: Le système a été mis en application pour une période de 8 semaines commençant en juin 1995. Il consistait en une évaluation systématique du patient et de sa médication, de même que de discussions au sein de l'équipe multidiciplinaire. Les 8 semaines précédant la mise en application du système, alors que les services pharmaceutiques étaient de nature plus traditionnels, ont servi de point de comparaison. Les variables comparées incluaient la durée du séjour à l'unité de soins, la durée du séjour hospitalier, les transferts vers les soins intensifs, les ré-admissions, et les réactions adverses nécessitant un traitement. Les différences avant/après ont été évaluées par le test du χ2 ou le test de t de Student avec un alpha de p < 0.05. La signification clinique des interventions a été évaluée de façon indépendante par quatre médecins: deux intensivistes et deux internistes. Les coûts nets générées par ces interventions ont été evaluées en soustrayant les coûts générés par les interventions des économies réalisées par celles-ci. RÉSULTATS: Le pharmacien a évalué 152 patients durant la période d'intervention. Un total de 235 recommandations pharmaceutiques ont été faites pour 103 patients; 86.4% de celles-ci ont été acceptées. Moins de réactions adverses ont nécessité un traitement durant l'intervention (p = 0.027). La durée moyenne d'un séjour à l'unité de soins était moins longue (4.8 ± 3.7 j vs. 6.0 ± 5.6 j); mais cette différence n'était pas statistiquement significative (p = 0.053). l'évaluation qu'ont faite les médecins des recommandations du pharmacien révèle que 75.8% des interventions étaient considérées quelque peu significatives, significatives, ou très significatives. Le changement de coûts a atteint -$6534.53, ce qui représente des économies annuelles de $42 474.45. CONCLUSIONS: Des soins pharmaceutiques à des patients d'une unité de soins progressifs ont été associés à de substantielles réductions dans le coût de la thérapie et une réduction des réactions adverses nécessitant un traitement.
APA, Harvard, Vancouver, ISO, and other styles
48

Mitchell, Joyce Leinberger. "Pharmaceutical care in an ambulatory care center." American Pharmacy 33, no. 12 (1993): 18. http://dx.doi.org/10.1016/s0160-3450(15)30587-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Fischer, LR, T. DeFor, S. Cooper, et al. "TPP3: PHARMACEUTICAL CARE AND HEALTH CARE UTILIZATION." Value in Health 2, no. 5 (1999): 373–74. http://dx.doi.org/10.1016/s1098-3015(10)75817-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Stuurman-Bieze, Ada G. G., Willem O. Boer, Mirjam E. A. P. Kokenberg, Jacqueline G. Hugtenburg, Lolkje T. W. Jong-van den Berg, and Th F. J. Tromp. "Complex Pharmaceutical Care intervention in Pulmonary Care." Pharmacy World & Science 27, no. 5 (2005): 376–84. http://dx.doi.org/10.1007/s11096-005-7112-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Pharmaceutical care' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography